Table 3.
HR | 95% CI | Pa | |
---|---|---|---|
Tumor-deposits absent in resected tumorb | |||
MSI (Unstable/High vs Stable/Low) | 0.89 | (0.79 – 0.997) | 0.044 |
KRAS (Mutated vs Wild type) | 1.24 | (1.14 – 1.35) | <0.001 |
Tumor-deposits present in resected tumorc | |||
MSI (Unstable/High vs Stable/Low) | 1.12 | (0.97 – 1.30) | 0.124 |
KRAS (Mutated vs Wild type) | 1.20 | (1.07 – 1.33) | 0.001 |
No tumor resectiond | |||
MSI (Unstable/High vs Stable/Low) | 0.51 | (0.24 – 1.08) | 0.078 |
KRAS (Mutated vs Wild type) | 2.07 | (1.33 – 3.22) | 0.001 |
MSI, microsatellite instability.
P of multivariate Cox regression analyses adjusted for age, tumor grade, pathologic stage, Charlson-Deyo score, chemotherapy status, radiotherapy status and race.
Age, pathologic stage and chemotherapy status included as time-varying covariates.
Tumor grade and chemotherapy status included as time-varying covariates.
Chemotherapy status included as time-varying covariate.